HIGHLIGHTS
- who: Circulating Tumor DNA Monitoring from the The study is an explorative single centre study (Clinicaltrialsgov: NCT03512847), conducted at Department of Clinical Oncology and Palliative Care, Zealand University Hospital. It was approved by The Regional have published the Article: OPEN ACCESS, in the Journal: (JOURNAL) of 18/04/2023
- what: The aim of the study was to investigate the clinical validity of ctDNA measurements during first-line treatment in advanced NSCLC by reporting on the correlation between ctDNA dynamics and treatment efficacy by radiologic evaluation. More precisely, the authors intended to measure the lead time . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.